Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07660445

Endoscopic Sleeve Gastroplasty Plus Duodenal pulsENDO for Obese T2DM

Conditions: Obesity Type 2 Diabetes Mellitus

Sex: All
Ages: 18 Years – 70 Years
Healthy volunteers: No
Phase: NA
Enrollment: 20
Sponsor: Chinese University of Hong Kong

Location: Prince of Wales Hospital, the Chinese University of Hong Kong Shatin

Summary

This study is designed to evaluate the efficacy, safety, and mechanisms of combining ESG and pulsENDO procedure in obese patients with T2DM

Eligibility Criteria

Inclusion Criteria: * BMI \>/= 27kg/m2 * Known T2DM * Individualized Metabolic Surgery (IMS) score 25-115 * HbA1c \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07660445). StuddyBuddy aggregates publicly available trial information.